Have a personal or library account? Click to login
Modulatory Role of Galectin-1 in Ulcerative Colitis with Comorbid Metabolic Syndrome Cover

Modulatory Role of Galectin-1 in Ulcerative Colitis with Comorbid Metabolic Syndrome

Open Access
|Aug 2023

Abstract

Metabolic syndrome (MetS) and ulcerative colitis (UC) are widespread health conditions characterized by chronic, low-grade inflammation. Galectin-1 (Gal-1), an immunomodulatory peptide mainly secreted from adipose tissue, could potentially play a crucial role in mitigating these conditions. This cross-sectional study explores the involvement of Gal-1 in MetS and UC within a cohort of 75 patients, newly diagnosed with UC. The MetS subgroup displayed increased fecal Gal-1 levels compared to those without MetS. Furthermore, Gal-1 showed predominance over pro-inflammatory cytokines, including TNF-α, IL-6, and IL-17, in these subjects. These findings emphasize the potential involvement of Gal-1 in the pathophysiology of UC and MetS, presenting it as a promising diagnostic biomarker and therapeutic target for these conditions.

DOI: https://doi.org/10.2478/eabr-2023-0006 | Journal eISSN: 2956-2090 | Journal ISSN: 2956-0454
Language: English
Submitted on: May 25, 2023
Accepted on: Jul 17, 2023
Published on: Aug 1, 2023
Published by: University of Kragujevac, Faculty of Medical Sciences
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2023 Kemal Corovic, Bojan Stojanovic, Andjela Petrovic, Isidora Stanisavljevic, Veljko Maric, Natasa Zdravkovic, Marina Jovanovic, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

AHEAD OF PRINT